Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
2007 1
2008 1
2010 1
2013 1
2014 4
2015 1
2017 2
2018 1
2019 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.
Thakur CP, Kumar A, Mitra G, Thakur S, Sinha PK, Das P, Bhattacharya SK, Sinha A. Thakur CP, et al. Indian J Med Res. 2008 Jul;128(1):38-44. Indian J Med Res. 2008. PMID: 18820357 Free article.
BACKGROUND & OBJECTIVE: Of the two reservoirs of infection of kala-azar i.e., patients of kala-azar and post kala-azar dermal leishmaniasis (PKDL), PKDL provides easy access for the sandfly to pick up the parasites. ...The number of cases of kala-azar …
BACKGROUND & OBJECTIVE: Of the two reservoirs of infection of kala-azar i.e., patients of kala-azar and post kala-azar …
Does immune dysregulation contribute towards development of hypopigmentation in Indian post kala-azar dermal leishmaniasis?
Sengupta R, Mitra S, Dighal A, Moulik S, Chaudhuri SJ, Das NK, Chatterjee U, Chatterjee M. Sengupta R, et al. Exp Dermatol. 2023 Jun;32(6):740-751. doi: 10.1111/exd.14760. Epub 2023 Feb 20. Exp Dermatol. 2023. PMID: 36760064
Post kala-azar dermal leishmaniasis (PKDL), a sequel of apparently cured visceral leishmaniasis (VL) presents with papulonodular (polymorphic) or hypopigmented lesions (macular) and is the proposed disease reservoir. ...
Post kala-azar dermal leishmaniasis (PKDL), a sequel of apparently cured visceral leishmaniasis (VL) presents with papulonodular (pol …
In-situ immune profile of polymorphic vs. macular Indian Post Kala-azar dermal leishmaniasis.
Sengupta R, Mukherjee S, Moulik S, Mitra S, Chaudhuri SJ, Das NK, Chatterjee U, Chatterjee M. Sengupta R, et al. Int J Parasitol Drugs Drug Resist. 2019 Dec;11:166-176. doi: 10.1016/j.ijpddr.2019.08.005. Epub 2019 Aug 22. Int J Parasitol Drugs Drug Resist. 2019. PMID: 31542359 Free PMC article.
Post Kala-azar Dermal Leishmaniasis (PKDL), a sequel of apparently cured Visceral Leishmaniasis presents in South Asia with papulonodular (polymorphic) or hypomelanotic lesions (macular). ...
Post Kala-azar Dermal Leishmaniasis (PKDL), a sequel of apparently cured Visceral Leishmaniasis presents in South Asia with papulonod …
Impaired activation of lesional CD8(+) T-cells is associated with enhanced expression of Programmed Death-1 in Indian Post Kala-azar Dermal Leishmaniasis.
Mukherjee S, Sengupta R, Mukhopadhyay D, Braun C, Mitra S, Roy S, Kanti Das N, Chatterjee U, von Stebut E, Chatterjee M. Mukherjee S, et al. Sci Rep. 2019 Jan 24;9(1):762. doi: 10.1038/s41598-018-37144-y. Sci Rep. 2019. PMID: 30679687 Free PMC article.
Post Kala-azar dermal leishmaniasis (PKDL), caused by Leishmania donovani is the dermal sequel of Visceral Leishmaniasis and importantly, is the proposed disease reservoir. ...
Post Kala-azar dermal leishmaniasis (PKDL), caused by Leishmania donovani is the dermal sequel of Visceral Leishmaniasis and importan …
Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.
Burza S, Sinha PK, Mahajan R, Sanz MG, Lima MA, Mitra G, Verma N, Das P. Burza S, et al. PLoS Negl Trop Dis. 2014 Jan 2;8(1):e2611. doi: 10.1371/journal.pntd.0002611. eCollection 2014. PLoS Negl Trop Dis. 2014. PMID: 24392171 Free PMC article.
BACKGROUND: The skin disorder Post Kala-Azar Dermal Leishmaniasis (PKDL) occurs in up to 10% of patients treated for visceral leishmaniasis (VL) in India. ...
BACKGROUND: The skin disorder Post Kala-Azar Dermal Leishmaniasis (PKDL) occurs in up to 10% of patients treated for visceral leishma …
Pharmacovigilance in kala-azar patients with severe thrombocytopenia caused by sodium antimony gluconate & miltefosine.
Thakur CP, Kumar A, Mitra G, Thakur S, Thakur M. Thakur CP, et al. Indian J Med Res. 2007 Jul;126(1):73-5. Indian J Med Res. 2007. PMID: 17890828 Free article.
Sodium antimony gluconate (SAG) and miltefosine used in the treatment of kala-azar are known to cause several side effects but severe thrombocytopenia has not been reported. ...One patient of miltefosine group treated outside only on the basis of rK-39 positivity did not s …
Sodium antimony gluconate (SAG) and miltefosine used in the treatment of kala-azar are known to cause several side effects but severe …
Cedrus deodara: In vitro antileishmanial efficacy & immumomodulatory activity.
Narayan S, Thakur CP, Bahadur S, Thakur M, Pandey SN, Thakur AK, Mitra DK, Mukherjee PK. Narayan S, et al. Indian J Med Res. 2017 Dec;146(6):780-787. doi: 10.4103/ijmr.IJMR_959_16. Indian J Med Res. 2017. PMID: 29664038 Free PMC article.
BACKGROUND & OBJECTIVES: The existing antileishmanial drugs for complete cure of visceral leishmaniasis (kala-azar) are limited. The available drugs are either toxic or less effective leading to disease relapse or conversion to post-kala-azar dermal leishmaniasi …
BACKGROUND & OBJECTIVES: The existing antileishmanial drugs for complete cure of visceral leishmaniasis (kala-azar) are limited. …
Improving outcome of treatment of kala-azar by supplementation of amphotericin B with physiologic saline and potassium chloride.
Thakur CP, Kumar A, Mitra DK, Roy A, Sinha AK, Ranjan A. Thakur CP, et al. Am J Trop Med Hyg. 2010 Nov;83(5):1040-3. doi: 10.4269/ajtmh.2010.10-0255. Am J Trop Med Hyg. 2010. PMID: 21036834 Free PMC article. Clinical Trial.
Complications of amphotericin B limit its wide application in the treatment of patients with kala-azar. This study was undertaken with an aim to minimize anti-renal complications and severe rigor in course of treatment with this drug. ...Supplementation of amphotericin B w …
Complications of amphotericin B limit its wide application in the treatment of patients with kala-azar. This study was undertaken wit …
High-Volume, High-Acuity, and High-Impact Learning: Tips and Tricks for Infectious Diseases Training Programs.
Luther VP, Paras ML, Schultz S, Aziz M, Balba G, McCarty TP, Razonable RR, Reece R, Shnekendorf R, Sundareshan V, Chirch LM; Infectious Diseases Society of America Infectious Diseases Training Program Directors Committee and Working Group. Luther VP, et al. Open Forum Infect Dis. 2024 Jan 8;11(3):ofae016. doi: 10.1093/ofid/ofae016. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38434609 Free PMC article.
19 results